| Satishkiran Reddy Kedika, MD | |
|
5645 Main St, Flushing, NY 11355-5045 | |
| (718) 445-0220 | |
| Not Available |
| Full Name | Satishkiran Reddy Kedika |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 13 Years |
| Location | 5645 Main St, Flushing, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225321250 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 25MA10369300 (New Jersey) | Primary |
| 2086S0129X | Surgery - Vascular Surgery | 285310 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jersey Shore University Medical Center | Neptune, NJ | Hospital |
| Bayshore Medical Center | Holmdel, NJ | Hospital |
| Southern Ocean Medical Center | Manahawkin, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
News Archive
A new and relatively little-known scientific discipline called molecular gastronomy has quietly revolutionized the dining experience in some famous restaurants and promises to foster a wider revolution in other restaurant and home kitchens. That's the conclusion of an article in ACS' Chemical Reviews, a monthly journal.
If a patient is no longer able to communicate personally how he or she would like to be treated, doctors and relatives consult an advance directive, if one is available. However, doctors and relatives often interpret patients' written wishes in different ways, as Nadja Leder et al. establish in their original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztbl Int 112: 723-9).
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
To speed healing at sites of injury - such as heart muscle after a heart attack or brain tissue after a stroke - doctors would like to be able to hasten the formation of new blood vessels.
› Verified 2 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
A new and relatively little-known scientific discipline called molecular gastronomy has quietly revolutionized the dining experience in some famous restaurants and promises to foster a wider revolution in other restaurant and home kitchens. That's the conclusion of an article in ACS' Chemical Reviews, a monthly journal.
If a patient is no longer able to communicate personally how he or she would like to be treated, doctors and relatives consult an advance directive, if one is available. However, doctors and relatives often interpret patients' written wishes in different ways, as Nadja Leder et al. establish in their original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztbl Int 112: 723-9).
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
To speed healing at sites of injury - such as heart muscle after a heart attack or brain tissue after a stroke - doctors would like to be able to hasten the formation of new blood vessels.
› Verified 2 days ago
| Entity Name | Meridian Medical Group-specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942362587 PECOS PAC ID: 6507962206 Enrollment ID: O20070425000673 |
News Archive
A new and relatively little-known scientific discipline called molecular gastronomy has quietly revolutionized the dining experience in some famous restaurants and promises to foster a wider revolution in other restaurant and home kitchens. That's the conclusion of an article in ACS' Chemical Reviews, a monthly journal.
If a patient is no longer able to communicate personally how he or she would like to be treated, doctors and relatives consult an advance directive, if one is available. However, doctors and relatives often interpret patients' written wishes in different ways, as Nadja Leder et al. establish in their original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztbl Int 112: 723-9).
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
To speed healing at sites of injury - such as heart muscle after a heart attack or brain tissue after a stroke - doctors would like to be able to hasten the formation of new blood vessels.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Satishkiran Reddy Kedika, MD 1511 Park Ave, South Plainfield, NJ 07080-5568 Ph: (908) 561-9500 | Satishkiran Reddy Kedika, MD 5645 Main St, Flushing, NY 11355-5045 Ph: (718) 445-0220 |
News Archive
A new and relatively little-known scientific discipline called molecular gastronomy has quietly revolutionized the dining experience in some famous restaurants and promises to foster a wider revolution in other restaurant and home kitchens. That's the conclusion of an article in ACS' Chemical Reviews, a monthly journal.
If a patient is no longer able to communicate personally how he or she would like to be treated, doctors and relatives consult an advance directive, if one is available. However, doctors and relatives often interpret patients' written wishes in different ways, as Nadja Leder et al. establish in their original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztbl Int 112: 723-9).
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
To speed healing at sites of injury - such as heart muscle after a heart attack or brain tissue after a stroke - doctors would like to be able to hasten the formation of new blood vessels.
› Verified 2 days ago
Dr. Frederic Weinbaum, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 5645 Main St, Rm-m204, Flushing, NY 11355 Phone: 718-445-0220 Fax: 718-939-1167 | |
Teagan Lynn Thorson, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 425-246-8328 | |
Steven Yeh-geng Chao, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, W-ll300, Flushing, NY 11355 Phone: 718-445-0220 Fax: 718-939-1167 | |
Li Tong Du, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-445-0220 Fax: 718-939-1167 | |
Dr. Chih-ching Hsu, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 4260 Main St, Medical Plaza, Suite B, Flushing, NY 11355 Phone: 718-886-4171 Fax: 718-886-4514 | |
Stephen Merola, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-445-0220 Fax: 718-939-1167 | |
Dr. Rafael Fazylov, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Rm M204, Flushing, NY 11355 Phone: 718-445-0220 Fax: 718-939-1167 |